XPRESHAN TECHNOLOGY

LIVE

Serial Number

88422524

Owner

GALDERMA HOLDING S.A.

Attorney

Katherine P. Califa

First Use Date

Feb 16, 2024

Filing Date

May 9, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

XPRESHAN TECHNOLOGY Trademark

Serial Number: 88422524 • Registration: 8005105

XPRESHAN TECHNOLOGY is a trademark filed by GALDERMA HOLDING S.A. on May 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

GALDERMA HOLDING S.A. (89 trademarks)

Zahlerweg 10
Zug 6300 , CH

Entity Type: 33

NESTLÉ SKIN HEALTH S.A. (128 trademarks)

AVENUE GRATTA-PAILLE 2
LAUSANNE 1018 , CH

Entity Type: 99

Legal Representation

Attorney of Record

Katherine P. Califa

1,770 trademarks filed View all →

Correspondence Address

Katherine P. Califa Foley & Lardner LLP

3000 K Street, N.W. Suite 600

Washington, DC 20007-5109

United States

Trademark Details

Filing Date

May 9, 2019

Registration Date

October 28, 2025

First Use Anywhere

February 16, 2024

First Use in Commerce

February 16, 2024

Published for Opposition

August 31, 2021

Goods & Services

Pharmaceutical preparations for use in augmentation of soft tissue, smoothing out wrinkles and fine lines, and contouring the face; kits consisting of syringes prefilled with pharmaceutical preparations for soft tissue augmentation, smoothing out wrinkles and fine lines, and contouring the face

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 28, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Oct 28, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 9, 2025 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 9, 2025 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 22, 2025 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 22, 2025 AITU

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 15, 2024 TCCA

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Nov 15, 2024 ECDR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

Nov 15, 2024 EWOR

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 15, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 15, 2024 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 15, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 15, 2024 COAR

USE AMENDMENT FILED

Oct 26, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Oct 26, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 24, 2024 EXRA

SOU EXTENSION 5 GRANTED

Apr 23, 2024 EX5G

SOU EXTENSION 5 FILED

Apr 23, 2024 EXT5

SOU TEAS EXTENSION RECEIVED

Apr 23, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 29, 2023 EXRA

SOU EXTENSION 4 GRANTED

Sep 27, 2023 EX4G

SOU EXTENSION 4 FILED

Sep 27, 2023 EXT4

SOU TEAS EXTENSION RECEIVED

Sep 27, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 4, 2023 EXRA

SOU EXTENSION 3 GRANTED

Mar 2, 2023 EX3G

SOU EXTENSION 3 FILED

Mar 2, 2023 EXT3

SOU TEAS EXTENSION RECEIVED

Mar 2, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 24, 2022 EXRA

SOU EXTENSION 2 GRANTED

Aug 22, 2022 EX2G

SOU EXTENSION 2 FILED

Aug 22, 2022 EXT2

SOU TEAS EXTENSION RECEIVED

Aug 22, 2022 EEXT

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 26, 2022 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 26, 2022 TCCA

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 26, 2022 COAR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 9, 2022 EXRA

SOU EXTENSION 1 GRANTED

Feb 7, 2022 EX1G

SOU EXTENSION 1 FILED

Feb 7, 2022 EXT1

SOU TEAS EXTENSION RECEIVED

Feb 7, 2022 EEXT

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 4, 2022 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 4, 2022 TCCA

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 4, 2022 COAR

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 26, 2021 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 31, 2021 NPUB

PUBLISHED FOR OPPOSITION

Aug 31, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 11, 2021 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 26, 2021 CNSA

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Jul 22, 2021 RCCK

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Dec 4, 2020 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Dec 4, 2020 TCCA

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Dec 4, 2020 ECDR

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 4, 2020 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 4, 2020 REAP

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Dec 4, 2020 COAR

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Nov 25, 2020 ASGN

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Sep 22, 2020 RCSC

ASSIGNED TO LIE

Aug 26, 2020 ALIE

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jan 28, 2020 GNS3

LETTER OF SUSPENSION E-MAILED

Jan 28, 2020 GNSL

SUSPENSION LETTER WRITTEN

Jan 28, 2020 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 23, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 23, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 23, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 24, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jul 24, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jul 24, 2019 CNRT

ASSIGNED TO EXAMINER

Jul 24, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 23, 2019 NWOS

NEW APPLICATION ENTERED

May 13, 2019 NWAP

Related Trademarks

More from this Owner

BARRIGEL

SOLESTA

RESTYLANE

More in Same Class

PREDNISOLONE PO4 / GATIFLOXACIN / BROMFENAC OPHTHALMIC SOLUTION 1% / 0.5% / 0.075% OMNI BY OSRX

PREDNISOLONE PHOSPHATE / GATIFLOXACIN /KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 1% / 0.5% / 0.5% OMNI BY OSRX

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX

TUMORGENESIS

NGSURE

PHYTOBIOMED